Palisades Investment Partners’s Veracyte VCYT Stock Holding History

Palisades Investment Partners’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Buy	175,034 +4,431	+3%	+$186K	2.92%	10
2026 Q1	$5.5M	Buy	170,603 +8,560	+5%	+$317K	2.15%	19
2025 Q4	$6.82M	Buy	162,043 +3,900	+2%	+$157K	2.58%	13
2025 Q3	$5.43M	Sell	158,143 -4,265	-3%	-$122K	2.13%	21
2025 Q2	$4.39M	Sell	162,408 -4,734	-3%	-$137K	1.92%	21
2025 Q1	$4.96M	Buy	167,142 +3,333	+2%	+$127K	2.49%	16
2024 Q4	$6.49M	Buy	+163,809	New	+$6.2M	2.74%	13

Other funds holding VCYT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Palisades Investment Partners's VCYT Position: Q2 2026 in Review

Palisades Investment Partners increased its Veracyte (VCYT) stake by 2.6% in Q2 2026, buying an estimated $186K and bringing the position to 175,034 shares worth $10.3M. The position accounts for 2.92% of the portfolio, ranked #10.

Palisades Investment Partners first reported a position in VCYT in Q4 2024 and has held it in 7 quarters since. 98 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Palisades Investment Partners held 175,034 shares of Veracyte worth $10.3M as of Q2 2026.
Palisades Investment Partners bought 4,431 Veracyte shares in Q2 2026, an estimated $186K.
Veracyte made up 2.92% of Palisades Investment Partners's portfolio in Q2 2026, its #10 holding.
Palisades Investment Partners first reported a position in Veracyte in Q4 2024 and has held it in 7 quarters since.
98 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Palisades Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.